Companion Diagnostics - Pharmaceuticals Research Report : Research Beam

1
Companion Diagnostics - Streamlining drug
development and advancing personalized medicine
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report Overview
Personalized healthcare encompasses tailored
diagnostics, treatment and management of
illnesses and diseases. Although the concept has
been around for many years, it is only with the
advent of companion diagnostics that personalized
healthcare has started to gain ground. Companion
diagnostics can be used in screening, monitoring,
diagnosing and treating patients and can allow
for stratification of patients to maximize
efficacy and minimize risk Companion diagnostics
can allow for a specific patient population to be
identified which will ensure those patients who
are most likely to respond are recruited for
clinical trials and receive the therapy once the
product is launched. Companion diagnostics can
help to rationalize treatment decisions, with
specifics such as accurate dosing, risks of
adverse events and diagnostics being made
possible through these tests. Through the use of
companion diagnostics, the right treatment can be
delivered to the right patient at the right time,
delivering greater value and optimizing
healthcare resource utilization Read More
Here http//www.researchbeam.com/companion-diagno
stics-streamlining-drug-development-and-advancing-
personalized-medicine-market
RESEARCH
No of Pages 250

3
Report Overview
Scope- Overview of personalized medicine and
companion diagnostics - Advantages and challenges
in the development of companion diagnostics -
Analysis of case studies - Future
outlook Reasons to buy- This report provides an
overview of advantages offered by companion
diagnostics from early clinical development
through to product launch and ongoing use in the
patient population - Understand what personalized
medicine and companion diagnostics are and how
these are expected to change the face of disease
management - Enables you to understand some of
the key challenges faced during the development
of companion diagnostics and recommendations on
how to overcome them - Provides an in-depth
analysis of key case studies highlighting the
successful application of companion diagnostics
and how this has impacted company activities
RESEARCH
No of Pages 250

4
Table of Content
Executive summary MethodologyPersonalized
medicine and companion diagnosticsPersonalized
medicine overviewWhat are biomarkers? What are
companion diagnostics?Advantages of companion
diagnostics A more targeted patient
populationFocused drug developmentRationalized
treatment decisionsPharmacoeconomic
advantagesChallenges in the development of
companion diagnosticsLogistical
challengesStrategic business challengesFinancial
risksRegulatory challengesCase
studies Enquire Heregtgtgthttp//www.researchbeam.co
m/companion-diagnostics-streamlining-drug-developm
ent-and-advancing-personalized-medicine-market/enq
uire-about-report
RESEARCH
No of Pages 250

5
RESEARCH
No of Pages 250